Jones Trading Downgrades Capricor Therapeutics (CAPR) to Hold
Jones Trading analyst Catherine Novack downgraded Capricor Therapeutics (NASDAQ: CAPR) from Buy to Hold.The analyst comments "What's New: An FDA ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)